The winding path of Illumina/Grail

The European Commission’s decision to prohibit Illumina’s already-completed acquisition of Grail brought an end to the administrative stage of a legal saga that has attracted interest beyond competition law specialists. Norton Rose Fulbright partner Miranda Cole examines the case’s highly-debated implications for the EU merger control regime in light of both the commission’s ruling and the EU General Court’s remarks on the matter so far.